Log In
BCIQ
Print this Print this
 

RgIA

  Manage Alerts
Collapse Summary General Information
Company Kineta Inc.
DescriptionNicotinic acetylcholine receptor (nAchR) antagonist derived from a cone snail venom protein
Molecular Target Nicotinic acetylcholine receptor (nAchR)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today